Metraipolis › archive › dc_994bbc0c64ca

Challenges in the translation and commercialization of cell therapies — Europe PMC PMID:26250902

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/26250902
DOI
10.1186/s12896-015-0190-4
License (as archived)
solo-consultazione
Archived
2026-10-08T08:10:36.205Z
SHA-256 of the archived text
75292e18fefb8ba303ee1d53c2cc901230a78d8da2c54ffea448026fc5b70e40
Stable URL of this page
https://metraipolis.com/documento/dc_994bbc0c64ca

How to cite

Challenges in the translation and commercialization of cell therapies — Europe PMC PMID:26250902 — Europe PMC (en), https://europepmc.org/article/MED/26250902 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_994bbc0c64ca (Metraipolis archive dc_994bbc0c64ca, sha256 75292e18fefb8ba303ee1d53c2cc901230a78d8da2c54ffea448026fc5b70e40)
BibTeX
@misc{dc994bbc0c64ca,
  title = {Challenges in the translation and commercialization of cell therapies — Europe PMC PMID:26250902},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/26250902},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_994bbc0c64ca; sha256 75292e18fefb8ba303ee1d53c2cc901230a78d8da2c54ffea448026fc5b70e40},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/26250902. Agents can read the archived copy with the MCP tool read_document.